蓝丰生化今日跌停，全天换手率45.41%，成交额11.84亿元，振幅22.22%。龙虎榜数据显示，机构净卖 出531.60万元，营业部席位合计净卖出2905.79万元。 深交所公开信息显示，当日该股因日振幅值达22.22%、日换手率达45.40%、日跌幅偏离值达-11.21%上 榜，机构专用席位净卖出531.60万元。 | 买/ | 会员营业部名称 | 买入金额（万 | 卖出金额（万 | | --- | --- | --- | --- | | 卖 | | 元） | 元） | | 买一 | 湘财证券股份有限公司绍兴平江路证券营业部 | 2409.94 | 0.00 | | 买二 | 国泰海通证券股份有限公司上海青浦区佳杰路证券营业 | 2121.42 | 73.65 | | | 部 | | | | 买三 | 国信证券股份有限公司浙江互联网分公司 | 1798.04 | 325.30 | | 买四 | 华鑫证券有限责任公司山东分公司 | 1771.93 | 0.00 | | 买五 | 东方财富证券股份有限公司拉萨金融城南环路证券营业 | 1727.81 | 632.02 | | | 部 | | | | 卖一 | ...

蓝丰生化今日涨停，全天换手率25.63%，成交额6.34亿元，振幅5.82%。龙虎榜数据显示，机构净买入 939.36万元，营业部席位合计净卖出4243.36万元。 深交所公开信息显示，当日该股因日换手率达25.63%上榜，机构专用席位净买入939.36万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交1.67亿元，其中，买入成交额为6702.98 万元，卖出成交额为1.00亿元，合计净卖出3304.00万元。 具体来看，今日上榜的营业部中，共有1家机构专用席位现身，即买五，买入金额943.57万元，卖出金 额4.21万元，合计净买入939.36万元。 资金流向方面，今日该股主力资金净流出3150.04万元，其中，特大单净流出4621.54万元，大单资金净 流入1471.50万元。近5日主力资金净流入1010.81万元。（数据宝） 蓝丰生化9月29日交易公开信息 | 买/卖 | 会员营业部名称 | 买入金额（万元） | 卖出金额（万元） | | --- | --- | --- | --- | | 买一 | 湘财证券股份有限公司绍兴平江路证券营业部 | 1890.28 | 2962.00 | | ...

蓝丰生化今日涨停，全天换手率31.16%，成交额6.22亿元，振幅16.74%。龙虎榜数据显示，机构净买入 694.44万元，营业部席位合计净卖出508.02万元。 深交所公开信息显示，当日该股因日振幅值达16.74%、日换手率达31.16%上榜，机构专用席位净买入 694.44万元。 买/卖 会员营业部名称 买入金额（万元） 卖出金额（万元） 买一 浙商证券股份有限公司苏州苏州大道东证券营业部 1680.86 0.00 买二 湘财证券股份有限公司绍兴平江路证券营业部 1600.74 924.00 蓝丰生化9月25日交易公开信息 | 买三 | 东吴证券股份有限公司苏州相城采莲路证券营业部 | 1417.55 | 2.50 | | --- | --- | --- | --- | | 买四 | 机构专用 | 1257.84 | 563.40 | | 买五 | 东吴证券股份有限公司苏州西北街证券营业部 | 1054.45 | 11.42 | | 卖一 | 财通证券股份有限公司杭州上塘路证券营业部 | 825.43 | 1285.37 | | 卖二 | 爱建证券有限责任公司杭州富春路证券营业部 | 0.00 | 12 ...

Core Viewpoint - The report outlines the fundraising and usage status of Zhejiang Xinong Chemical Co., Ltd. (hereinafter referred to as "the Company") as of the first half of 2025, indicating that all raised funds have been utilized or permanently supplemented into working capital, with no remaining balance in the special accounts [1][2][8]. Fundraising Overview - The Company raised a total of RMB 429.90 million by issuing 30 million shares at RMB 14.33 per share, with net proceeds amounting to RMB 403.90 million after deducting underwriting fees and other expenses [1][2]. - The funds were deposited into designated bank accounts, including RMB 82.69 million in China Construction Bank, RMB 60 million in Agricultural Bank of China, and RMB 60 million in Industrial and Commercial Bank of China [1]. Fund Usage and Balance - As of June 30, 2025, the Company had utilized RMB 231.99 million in previous years and RMB 3.05 million in the current year, with a total interest income of RMB 41.92 million from bank deposits [2][3]. - The remaining balance of the raised funds, including interest and cash management income, was zero, with RMB 189.63 million permanently supplemented into working capital [2][3]. Fund Management - The Company established a special account system for managing the raised funds, signing tripartite and quadripartite supervision agreements with banks and the sponsor, Everbright Securities [3][5]. - All seven special accounts for the raised funds have been closed as of June 30, 2025, ensuring compliance with regulations [5][6]. Project Implementation and Adjustments - The Company has terminated the "Annual Production of 1,000 Tons of Pyrazole Ester and By-product 430 Tons of Sodium Chloride Project" due to external market conditions affecting project feasibility and expected returns [8][9]. - The remaining funds from terminated projects have been permanently supplemented into working capital to support daily operations [8][9]. Compliance and Verification - Everbright Securities conducted a compliance review and confirmed that the Company's management and usage of the raised funds adhered to relevant regulations, with no violations or misappropriations identified [8][9].